Science

“Something Just Clicked”: Partnership Pushes New Class of Cancer Drug Toward Human Trials

Serguei Kozlov, Ph.D., doesn’t recall if it was he who first contacted clinician Udo Rudloff, M.D., Ph.D., or Rudloff who contacted him. He just knows that their resulting two-year collaboration, which recently moved a first-in-class drug for metastatic cancer toward clinical trials, is one of the best he’s ever had.

Tags: 

NICBR Winter Symposium Focuses on Novel Therapeutics Research

Attendees packed the Building 549 Conference Center for the National Interagency Confederation for Biological Research (NICBR) Winter Symposium, the latest in a series that aims to foster collaboration between its eight member agencies. Each symposium focuses on a specific theme, with the most recent event organized around novel therapeutics.

Tags: 

“A Stellar and Beautiful Building”: 538 Renovation Reaches Completion

When NCI at Frederick began receiving royalty money from the HPV vaccine research by Doug Lowy, John Schiller, and colleagues, a portion was set aside for facilities renovations on the NCI at Frederick campus. One of the first spaces slated for renovation was Building 538, which was mainly occupied by Center for Cancer Research (CCR) scientists.

Tags: 

Pages

Subscribe to Science